全球泌尿道感染檢測市場規模、佔有率、成長分析、依感染類型、依測試類型、依最終用戶、依測試套件 - 產業預測 2024-2031

2022 年，全球泌尿道感染檢測市場規模為 87 億美元，預計將從 2023 年的 90.6 億美元成長到 2031 年的 124.9 億美元，預測期內（2024-2031 年）複合CAGR為 4.1%。

由於診斷技術的進步和人們對泌尿道感染 (UTI) 認知的提高，全球泌尿道感染 (UTI) 檢測市場正在不斷發展。泌尿道感染是常見的細菌感染，主要影響全世界的女性。推動尿路感染檢測市場的因素包括尿路感染病例數量的增加、醫療保健支出的增加以及容易感染這些感染的老年人口的增加。技術進步催生了準確且高效的診斷工具，例如即時檢測和非侵入性方法，改善了泌尿道感染的早期檢測和治療。此外，對個人化和預防性醫療保健的關注促使醫療保健提供者使用先進的診斷解決方案，增加了對泌尿道感染檢測產品的需求。然而，與某些測試方法的準確性和替代療法的可用性相關的課題可能會稍微減緩市場成長。隨著醫療保健產業繼續優先考慮感染管理，尿路感染檢測市場預計未來將穩定成長。

目錄

執行摘要

• 市場概況
• 命運之輪

研究方法論

• 資訊採購
• 二手和主要資料來源
• 市場規模估計
• 市場假設與限制

母公司市場分析

• 市場概況
• 市場規模
• 市場動態
  • 促進要素
  • 機會
  • 限制
  • 課題

主要市場洞察

• 技術分析
• 定價分析
• 供應鏈分析
• 價值鏈分析
• 市場生態系統
• 智慧財產權分析
• 貿易分析
• 啟動分析
• 原料分析
• 創新矩陣
• 管道產品分析
• 總體經濟指標
• 頂級投資分析
• 成功的關鍵因素
• 競爭程度

市場動態與展望

• 市場動態
  • 促進要素
  • 機會
  • 限制
  • 課題
• 監管環境
• 波特分析
• 對未來顛覆的特別見解

依感染類型分類的全球尿路感染檢測市場

• 市場概況
• 尿道炎
• 膀胱炎
• 腎盂腎炎

依測試類型分類的全球尿路感染檢測市場

• 市場概況
• 尿液分析
• 尿液培養
• 藥敏試驗

全球尿路感染檢測市場（依最終用戶）

• 市場概況
• 醫院
• 診斷實驗室
• 研究機構

全球尿路感染檢測市場（依檢測試劑盒）

• 市場概況
• 家庭測試套件
• 實驗室測試套件

全球尿路感染檢測市場規模（依地區）

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 歐洲其他地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 拉丁美洲其他地區
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • MEA 的其餘部分

競爭格局

• 前 5 名玩家比較
• 2021 年關鍵參與者的市場定位
• 主要市場參與者所採取的策略
• 最佳制勝策略
• 近期市集活動
• 主要公司市佔率（%），2021年

主要公司簡介

• QIAGEN (Germany)
• Accelerate Diagnostics, Inc. (US)
• Bio-Rad Laboratories, Inc. (US)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Danaher Corporation (US)
• Siemens Healthcare GmbH (Germany)
• Randox Laboratories Ltd. (UK)
• Thermo Fisher Scientific, Inc. (US)
• bioMerieux SA (France)
• T2 Biosystems, Inc. (US)
• Beckman Coulter, Inc. (US)
• Becton, Dickinson and Company (US)
• Sysmex Corporation (Japan)
• Cepheid (US)
• GenMark Diagnostics, Inc. (US)
• Hologic, Inc. (US)
• Ortho Clinical Diagnostics (US)
• Luminex Corporation (US)
• Bruker Corporation (US)
• Trinity Biotech plc (Ireland)

Global Urinary Tract Infection Testing Market size was valued at USD 8.7 billion in 2022 and is poised to grow from USD 9.06 billion in 2023 to USD 12.49 billion by 2031, growing at a CAGR of 4.1% in the forecast period (2024- 2031).

The global market for testing urinary tract infections (UTIs) is evolving due to improvements in diagnostic technologies and increased awareness about UTIs. UTIs are common bacterial infections that mainly affect women worldwide. Factors driving the UTI testing market include the rising number of UTI cases, more spending on healthcare, and a growing elderly population prone to these infections. Technological advancements have led to the creation of accurate and efficient diagnostic tools, such as point-of-care tests and non-invasive methods, improving early detection and treatment of UTIs. Also, the focus on personalized and preventive healthcare has led to healthcare providers using advanced diagnostic solutions, increasing the demand for UTI testing products. However, challenges related to the accuracy of some testing methods and the availability of alternative treatments may slightly slow market growth. As the healthcare sector continues to prioritize infection management, the UTI testing market is expected to grow steadily in the future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Urinary Tract Infection Testing Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Urinary Tract Infection Testing Market Segmental Analysis

The global urinary tract infection testing market is segmented on the basis of Infection Type, Test type, end-user, Test kit and region. By Infection type, the market is segmented into Urethritis, Cystitis, Pyelonephritis. By Test type, the market is segmented into Urinalysis , Urine Cultures, Susceptibility Testing. By End-User, the market is segmented into Hospitals, Diagnostic Laboratories, Research Institutes. By Test kit, the market is segmented into Home Test Kits, Laboratory Test Kits. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Urinary Tract Infection Testing Market

The global market for urinary tract infections (UTIs) is greatly affected by the increasing prevalence of antibiotic-resistant UTIs. The misuse and overuse of antibiotics have caused bacteria to become resistant to traditional treatments, making UTI management more complex. This urgent issue has created a demand for precise diagnostic tools like urine cultures and susceptibility testing. These tools help healthcare providers identify effective treatment options tailored to specific bacterial strains. Furthermore, the need to address antibiotic resistance has led to investments in research and development for new therapies. This focus on innovation is shaping the market toward solutions that combat resistant UTIs while promoting responsible antibiotic use.

Restraints in the Global Urinary Tract Infection Testing Market

Antibiotic resistance is a major obstacle in the global urinary tract infection (UTI) market. Overusing and misusing antibiotics have caused drug-resistant bacteria to emerge, making commonly used antibiotics less effective in treating UTIs. This issue makes treatment decisions more complicated and can lead to longer infections, higher healthcare expenses, and potential complications. Healthcare providers must carefully balance effective treatment with responsible antibiotic use to address this growing problem. This highlights the need for alternative treatment methods and diagnostic strategies in the UTI market.

Market Trends of the Global Urinary Tract Infection Testing Market

A notable trend in the global urinary tract infection (UTI) market is the increasing use of Point-of-Care (POC) testing methods. These tests provide fast results and convenient on-the-spot diagnostics, eliminating the need for centralized laboratory facilities and reducing turnaround times. This trend meets the demand for quick and accurate UTI diagnosis, especially in primary care settings. The adoption of POC testing technologies enables healthcare professionals to make timely treatment decisions, improve patient outcomes, and optimize resource allocation. As technology advances improve the accuracy and efficiency of POC tests, their widespread use is changing the landscape of UTI diagnostics.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Regulatory Landscape
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact

Global Urinary Tract Infection Testing Market by Infection Type

• Market Overview
• Urethritis
• Cystitis
• and Pyelonephritis

Global Urinary Tract Infection Testing Market by Test Type

• Market Overview
• Urinalysis
• Urine Cultures
• Susceptibility Testing

Global Urinary Tract Infection Testing Market by End-user

• Market Overview
• Hospitals
• Diagnostic Laboratories
• Research Institutes

Global Urinary Tract Infection Testing Market by Test Kit

• Market Overview
• Home Test Kits
• Laboratory Test Kits

Global Urinary Tract Infection Testing Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2021
• Strategies Adopted by Key Market Players
• Top Winning Strategies
  • By Development
  • By Company
  • By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2021

Key Company Profiles

• QIAGEN (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Accelerate Diagnostics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthcare GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• T2 Biosystems, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cepheid (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenMark Diagnostics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ortho Clinical Diagnostics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luminex Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trinity Biotech plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments